awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28067436-261D26AE-9C42-4FCF-A48D-870AF09260F1
Q28067436-261D26AE-9C42-4FCF-A48D-870AF09260F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067436-261D26AE-9C42-4FCF-A48D-870AF09260F1
Novel therapeutic strategies for patients with triple-negative breast cancer
P2860
Q28067436-261D26AE-9C42-4FCF-A48D-870AF09260F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067436-261D26AE-9C42-4FCF-A48D-870AF09260F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81b1c6f7bf098cc9401462b171e25fb1ee86a3e8
P2860
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).